Evatanepag, also known as CP-533536, is an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing.
Molekulargewicht:
490.55
CAS Nummer:
[223490-49-1]
Formel:
C25H27N2NaO5S
Target-Kategorie:
Others|||Prostaglandin Receptor
T69755
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten